PHARMACOGENETICS IN PEDIATRICS
- 1 February 1997
- journal article
- review article
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 44 (1) , 55-77
- https://doi.org/10.1016/s0031-3955(05)70463-6
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Nomenclature for human CYP2D6 allelesPharmacogenetics, 1996
- Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in manJournal of Clinical Endocrinology & Metabolism, 1996
- Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activityPharmacogenetics, 1995
- Drug Interactions and the Cytochrome P450 SystemClinical Pharmacokinetics, 1995
- Involvement of CYP2D6, CYP3A4, and other cytochrome P-450 isozymes in N-dealkylation reactionsJournal of Pharmacological and Toxicological Methods, 1994
- Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.British Journal of Clinical Pharmacology, 1994
- Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolitesPharmacogenetics, 1992
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.Proceedings of the National Academy of Sciences, 1989
- ALTERED THEOPHYLLINE PHARMACOKINETICS DURING ACUTE RESPIRATORY VIRAL ILLNESSThe Lancet, 1978